View Cart

News, Policy & Economics

Interview: What Biden’s Covid Czar Learned From the Pandemic

By By Sara Talpos, Originally published Nov 2024 on Undark

Ashish Jha, the dean of Brown University’s School of Public Health, served as the White House Covid-19 response coordinator from March 2022 to June 2023. On Monday, after delivering the keynote for an infectious disease symposium at the University of Michigan, Jha sat down with Undark to discuss what the country got wrong, and what […]

Read more ...

Trump 2.0: Implications for Holistic Medicine

By Erik Goldman

Healthcare was not a high-priority campaign issue for either candidate in 2024. But Donald Trump’s nomination of Robert F. Kennedy, Jr, to head the Department of Health & Human Services, and Mehmet Oz, MD, to run the Centers for Medicare and Medicaid Services, as well as his promises to tame drug costs, eliminate Medicare fraud, […]

Read more ...

The Leapfrog Effect: New Tech Moves Tests, Treatments Out of the Clinic

By Erik Goldman

For a lot of people these days, medical clinics are no longer the center of the healthcare equation like they were in the past: their smartphones are now the point of focus. An astonishing number of medical tests, treatments, and services have jumped out of the clinic and into peoples’ daily lives via their computers, […]

Read more ...

In Memoriam: Gladys T. McGarey, MD (Nov 30, 1920 – Sept 28, 2024)

By Erik Goldman

The cosmologists tell us we are made of ‘star-stuff,’ that the elements and energies of which we are comprised have their origins in the sun. For most of us, that’s theoretical. But some people seem to embody this truth. Their very presence emanates a certain shine that illuminates and invigorates everyone and everything around them. […]

Read more ...

How the FDA Could Shape the Future of Psychedelics Research

By Joshua Cohen

(Originally published by www.undark.org, Aug 5, 2024) In August, the US Food and Drug Administration decided not to approve the psychedelic drug MDMA (midomafetamine) for use in patients with post-traumatic stress disorder in conjunction with psychological intervention. The move signals the FDA’s desire to put the brakes on the psychedelics research, which has rapidly  moved […]

Read more ...

In Memoriam: Norman Shealy, MD

By Erik Goldman

“To me, everything is energy.” That’s the sort of statement one would expect from a shaman, or perhaps a theoretical physicist, not from a neurosurgeon. But Norman Shealy was not a typical neurosurgeon. Over a clinical and research career spanning nearly 70 years, Dr. Shealy challenged and expanded the boundaries of neuroscience in ways that […]

Read more ...

A “RIGID” Stance Against Research Fraud

By Erik Goldman

Researchers at Monash University in Australia are calling on the global medical community to adopt their new six-step approach to detect and eliminate fraudulent studies before they are incorporated into metanalyses, clinical guidelines, and “best practices.” The RIGID (Research Integrity in Guidelines and evIDence) system is positioned as an international framework for addressing the massive […]

Read more ...

South Park’s Scathing Critique of US Healthcare

By Erik Goldman, Editor

The End of Obesity, a new episode of the viciously satirical cartoon series, South Park, is a merciless excoriation of American healthcare, one that has some physicians commenting that the show is more documentary than parody. Currently running exclusively on Paramount Plus, this latest installment of the long-running show centers on the rotund Eric Cartman, […]

Read more ...

FDA Increases Oversight of Diagnostic Tests

By Erik Goldman, Editor

The Food and Drug Administration has issued new rules aimed at bolstering the agency’s oversight and regulation of the diagnostic testing field. Specifically, the FDA is taking aim at Laboratory-Developed Tests (LDTs), which are defined as in vitro medical tests designed, manufactured, and processed by a single clinical laboratory. Historically, LDTs were unique, highly targeted […]

Read more ...

Microplastics: A New Cardiovascular Risk Factor

By Erik Goldman, Editor

The presence of micro- or nano-plastic particles in carotid atheromas significantly raises the risk of myocardial infarction, stroke, or death from any cause within 3 years. That’s the blunt conclusion of a new multi-center study headed by researchers at the Department of Advanced Medical & Surgical Science, University of Campania, Naples, and involving more than […]

Read more ...

Copyright © 2024 Holistic Primary Care. All Rights Reserved.